Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
6.90
-0.19 (-2.68%)
At close: Jun 27, 2025, 4:00 PM
6.91
+0.01 (0.14%)
After-hours: Jun 27, 2025, 7:54 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $28.20 million as of June 27, 2025. Its market cap has decreased by -60.94% in one year.
Market Cap
28.20M
Enterprise Value
19.88M
1-Year Change
-60.94%
Ranking
Category
Stock Price
$6.90
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $28.20M, a decrease of -68.18%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 25.41M | -30.23% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.95B |
| Johnson & Johnson | 367.00B |
| AbbVie | 328.36B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 273.68B |
| Abbott Laboratories | 239.21B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |